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Introduction: The incidence of multiple intracardiac mass is rare. The differential diagnosis of intracavitary mass
lesions includes benign, malignant primary, secondary metastatic cardiac tumors, or thrombus.
Case presentation: We report the case of a 49-year-old Asian woman, who experienced a 2-week history of
progressive exertional dyspnea, orthopnea, bilateral lower limb edema and palpitations. Transthoracic
echocardiography showed one fixed round hyperechoic mass with central necrosis over the left ventricular apex,
one oscillating hyperechoic nodule over the anterior mitral annulus and one irregularly heterogeneous mass
bulging out from the lateral wall of the right atrium. The incidence of multiple myxomas is rare. Unfortunately, high
tumor marker, serum lactic dehydrogenase and serum uric acid levels were also present. We could not differentiate
between diagnoses of multiple myxomas with thrombi or multiple metastatic tumors.
Conclusions: Primary intracardiac tumors are rare. Approximately 75% are benign, and approximately 50% are
myxomas, which have an incidence of 0.0017% in the general population. Multiple intracardiac myxomas account for
less than 5% of all cases of myxoma. Our case was an atypical picture of right atrial (RA) myxoma, as it was located in
the RA lateral wall and extended to the RA auricle at the junction among the superior and inferior vena cava. Two
masses in the left ventricle (LV) were thrombi and resolved after heparinization. Initially, elevated tumor markers and
high serum uric acid and high serum lactic dehydrogenase levels were related to necrotic tumor-derived tissue,
decompensated heart failure with pleural effusion and renal insufficiency. We share our experience of multiple
intracardiac masses. Whether the intracardiac mass is benign or malignant, we recommend surgery due to the
possibilities of systemic or pulmonary massive embolism, infection, arrhythmia and sudden death if the thrombus
ruptures or the mass dislodges.
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The incidence of multiple intracavitary masses is rare.
Echocardiography is a good tool to detect intracardiac
masses, and the differential diagnosis must include
thrombus, vegetation and a foreign body. Multiple intra-
cardiac myxomas account for less than 5% of all cases of
multiple intracardiac masses [1]. Secondary or metastatic
tumors are 20–40 times more frequent than primary tu-
mors. We share our experience about the approach to
multiple intracardiac masses and show evidence of intra-
cardiac thrombus resolution after treatment.* Correspondence: Morganfu@hotmail.com
†Equal contributors
1Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang
Gung Memorial Hospital, Chang Gung University. College of Medicine, 123,
Ta Pei Road, Kaohsiung City 83301, Taiwan
Full list of author information is available at the end of the article
© 2015 Lee et al. Open Access This article i
International License (http://creativecommo
reproduction in any medium, provided you
link to the Creative Commons license, and
Dedication waiver (http://creativecommons
article, unless otherwise stated.Case presentation
A 49-year-old Asian woman without systemic disease
was admitted to our hospital with a 2-week history of
progressive exertional dyspnea, orthopnea, bilateral
lower limb edema and palpitation. Previously, she had
been in good health except for mildly elevated blood
pressure. A physical examination revealed a blood pres-
sure of 195/138mmHg and a rapid pulse rate of 163
beats/minute. Jugular venous distention to 18 cm was
noted, a chest examination revealed bilateral lower lung
crackles, and a cardiac examination showed an irregu-
larly rapid beat without an audible murmur. No palpable
mass was detected in her neck, axillary or inguinal areas.
Her lower limbs showed grade II edema. An electrocar-
diogram showed atrial flutter. Chest radiography showed
a lower left lung patch and bilateral lung infiltrations distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
Fig. 2 On transthoracic echocardiogram, one irregular and
heterogeneous mass (5.6cm2) over the lateral wall of the right
atrium (RA) (white arrow)
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dimer (14.14mg/L). Biochemistry test results revealed
renal insufficiency (creatinine 3.11mg/dL) and high serum
lactic dehydrogenase (LDH) (1367U/L) and uric acid
(20.9mg/dL) levels. Mildly elevated troponin-I (0.067ng/
mL), creatine kinase-MB (CK-MB) (11.9ng/mL and B-
natriuretic peptide (BNP) (704pg/mL) were also present.
Transthoracic echocardiography (TTE) showed one fixed
round hyperechoic mass with central necrosis over the left
ventricular apex, one oscillating hyperechoic nodule over
the anterior mitral annulus and one irregular and hetero-
geneous mass bulging out from the lateral wall of the right
atrium (RA) (Figs. 2 and 3; Additional file 1: Video S1).
Multiple intracardiac masses were noted, and malig-
nancy was suspected. Elevated tumor markers were noted,
and her cancer antigen 125 (CA-125) level was 298.10U/
mL, cancer antigen 199 (CA-199) was 52.00U/mL and
cancer antigen 153 (CA-153) was 33.80U/mL. Cardiac
magnetic resonance imaging (MRI) was arranged for dif-
ferential diagnosis of multiple intracardiac masses. The
image showed one 6.0 × 2.3cm lobulated mass bulging
out from the lateral wall of the RA along with another two
small nodules in the left ventricular apex and anterior as-
pect of the mitral valve. The one RA mass and two LV
masses did not invade into the cardiac walls. All masses
were near isointense on T1-weighted image (T1WI) and
hyperintense on T2-weighted image (T2WI). We favored
a multiple myxoma diagnosis (Fig. 4).
On enhanced chest computed tomography (CT), a
consolidated patch with central necrosis over the lower
left lung and enlarged left anterior mediastinal and right
paratracheal lymph nodes were also noted (Fig. 5).Fig. 1 Lower left lung patch (white arrow) and bilateral lung infiltrationHowever, no definite lung nodule or mass or pulmonary
embolism was detected on her chest CT scan. Despite
these findings and the high tumor marker, we could not
differentiate between diagnoses of multiple myxomas or
multiple metastatic lung tumors.
Heparinization was administered and her sinus
rhythm spontaneously returned 2 days after medical
treatment for heart failure and atrial flutter. Fortu-
nately, her renal function improved and her serum
LDH and uric acid levels returned to normal a few
days later. We arranged a lung biopsy and echo-guided
cardiac biopsies for an advanced etiologic survey. How-
ever, repeat cardiac biopsies and lung biopsies can only
detect necrotic tissues or blood clots. Therefore, an open-
heart biopsy and tumor excision were performed 3 weeks
later and showed an RA lateral wall tumor with clots over
its surfaces. The tumor extended to the RA auricle at the
junction among the superior vena cava (SVC), RA and in-
ferior vena cava (IVC). RA mass pathology with a 10 times
view showed myxoma (5.1 × 3.1 × 1.5cm3) in which the
left side was composed of muscle cells and the right side
contained bland-looking, oval-shaped stellate tumor cells
on a fibromyxoid background (Fig. 6). Interestingly, no
mass was found in the LV, and the thrombus disappeared
after heparinization.
Fig. 4 On cardiac magnetic resonance imaging (MRI) as cardiac-gated, cine
2.3cm lobulated mass bulging out from the lateral wall of the right atrium
ventricular apex (d; black arrow). LV: left ventricle
Fig. 3 One fixed round hyperechoic mass with central necrosis over
the left ventricular apex (upper black arrow), and one oscillating
hyperechoic nodule over the anterior mitral annulus (lower black arrow).
LV: left ventricle
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that resolved after heparinization. At a follow-up 1 year
after surgery, our patient had returned to her daily activ-
ities, and all laboratory data, including tumor markers,
had returned to normal ranges. Subsequent TTE showed
adequate LV performance, and there were no further
atrial flutter episodes. The consolidated patch over the
lower left lung, which we favored as an arrhythmia- or
myxoma-related emboli-induced lung patch, also re-
solved 1 month later. We suspected that initially ele-
vated tumor markers and high uric acid and high LDH
levels were related to necrotic tumor-derived tissue, de-
compensated heart failure with pleural effusion and
renal insufficiency.Discussion
The incidence of multiple intracavitary masses is rare.
The differential diagnosis of intracavitary mass lesions
includes benign, malignant primary, secondary meta-
static cardiac tumors and thrombus. Because an intra-
cardiac lesion can be detected by echocardiography, the
differential diagnosis must include thrombus, vegetation
and a foreign body. However, intracardiac metastases,
even though rare, should also be included in thegradient-echo “bright blood” magnetic resonance images, one 6.0 ×
(RA) (a, b, c; black arrows) and another small nodule in the left
Fig. 5 On enhanced chest computed tomography (CT), a
consolidated patch with central necrosis over the lower left lung
(white arrow)
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rial thrombotic or marantic endocarditis [2].
Cardiac tumors represent 0.2% of all tumors found in
humans. These tumors are divided into primary or sec-
ondary/metastatic. Secondary or metastatic tumors are
20–40 times more frequent than primary tumors. Pri-
mary intracardiac tumors are rare. Approximately 75%Fig. 6 Ten times view showed that the left side was composed of muscle
tumor cells on a fibromyxoid background (black arrows)are benign, and approximately 50% are myxomas, which
have an incidence of 0.0017% in the general population
[3]. Atrial myxomas are the most common (approxi-
mately 20–30%) primary intracardiac tumor in adults.
Two-thirds of myxomas arise in the left atrium, whereas
others arise in the RA, ventricles, SVC or pulmonary
veins [4]. Only 15–20% of cardiac myxomas originate
from the RA [5]. Multiple intracardiac masses are rare,
and multiple intracardiac myxomas account for less than
5% of all cases [1]. The typical myxoma morphology is
generally polypoid, often pedunculated, rarely sessile and
round or oval, with a smooth or gently lobulated surface
as observed by echocardiography [6]. RA myxomas usu-
ally originate in the fossa ovalis or the base of the intera-
trial septum [7]. Our case was an atypical picture of RA
myxoma, as it was located in the RA lateral wall and ex-
tended to the RA auricle at the junction among the SVC
and IVC. Two masses in the LV were thrombi and re-
solved after heparinization. The lower left lung consoli-
dation was a suspected pulmonary thromboembolism,
and also resolved after anticoagulation therapy. High
levels of tumor markers, LDH and uric acid indicated a
possible diagnosis of secondary malignancy.
Imaging modalities such as CT and MRI can provide
additional information when echocardiography cannot
delineate the extent of cardiac wall involvement. If myx-
oid tissue is abundantly available, the lesion will have an
elevated signal in the T2WI, whereas if the fibrous com-
ponent prevails, the mass will appear hypointense. En-
hancement of the tumor is correlated with its histology,
and the areas that are not enhanced upon imaging ana-
lysis correspond to necrosis or cystic degeneration.cells and the right side showed bland-looking oval-shaped stellate
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and thrombi; the latter do not appear enhanced except
in rare cases of vascularized thrombi [8].
Myxoma surfaces may have smooth or lobulated
macroscopic features. Oval, rounded, and irregular
shapes have been described, and a brownish color ap-
pears to predominate. The consistency of myxomas also
varies from firm to gelatinous. The microscopic features
of myxomas are characterized by a myxoid matrix rich
in mucopolysaccharides in which polygonal cells with an
eosinophilic cytoplasm can be detected. The polygonal
cells may appear as star- or nest-shaped and may be
multinucleated. Microscopic characteristics including
mitoses, necrosis, or pleomorphisms are usually not de-
tected or are eventually present as mild findings [3].
The classic triad found in patients with cardiac myx-
oma is characterized by obstruction of blood flow, con-
stitutional symptoms and thromboembolic events. The
obstruction of blood flow leads to intermittent heart fail-
ure, and, similar to systemic nonspecific flu-like malaise
symptoms, there is usually a low fever of long duration,
arthralgia, anorexia, and thromboembolic events. RA
myxoma in particular can obstruct the tricuspid valve,
causing signs and symptoms of right-sided heart failure,
peripheral edema, ascites, hepatic congestion, and syn-
cope. The signs and symptoms caused by myxomas are
atypical and highly variable and can result in a difficult
diagnosis of this neoplasia. According to the size, mobil-
ity and location of the tumor as well as physical activity
and body position, patients may have an asymptomatic
course or progress with thromboembolic events that
may even lead to sudden death [9, 10]. We share our ex-
periences regarding RA myxomas with LV thrombi and
show evidence of thrombi resolution by heparinization.
Whether the intracardiac mass is benign or malignant,
we still recommend surgery due to the possibilities of
systemic or pulmonary massive embolism, infection,
arrhythmia and sudden death if a thrombus ruptures or
the mass dislodges.
Conclusions
We share our experiences regarding an atypical picture
of RA myxoma, which was located in the RA lateral wall
with extension to the RA auricle at the junction among
the SVC, RA and IVC. Initially, clinical presentation was
arrhythmia as atrial flutter and decompensated heart
failure. This myxoma was also accompanied by two LV
thrombi and pulmonary thromboembolism. Although
high tumor markers, LDH and uric acid levels suggested
a possibly secondary malignancy diagnosis. The most
common mass was thrombus. In our case, the LV
thrombi and pulmonary thromboembolism were re-
solved by heparinization. Whether the intracardiac mass
is benign or malignant, we recommend surgery due tothe possibilities of systemic or pulmonary massive em-
bolism, infection, arrhythmia and sudden death if the
thrombus ruptures or the mass dislodges.
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